After Hours
$
144.60
Change
-0.24 -0.17%
Volume
Volume 170,265
Feb 2, 2023, 7:59 p.m.
Quotes are delayed by 20 min
Today's close
$ 146.60
$ 144.84
Change
-1.76 -1.20%
Day low
Day high
$143.44
$145.93

52 week low
52 week high
$134.09
$175.91

Market cap
$259.26B
Average volume
5.41M
P/E ratio
19.30
Rev. per Employee
$1.16M
EPS
7.50
Dividend
1.48
Div yield
4.09%
Ex dividend date
1/12/23
MarketWatch News on ABBV
-
First Humira Biosimilar Price Highlights Cost-Saving Challenges
- Josh Nathan-Kazis
-
How to Play Corporate Bonds as Defaults Start to Bite
- Lawrence C. Strauss
-
Price Negotiations Are About to Reshape the Drug Industry
- Josh Nathan-Kazis
-
These 15 Dividend Aristocrat stocks have been the best income builders
- Philip van Doorn
-
AbbVie cuts earnings forecast due to milestone payments
- Wallace Witkowski
-
CytomX shares surge more than 50% on Moderna partnership
- MarketWatch
-
Dividend Stocks Are for Choppy Times. Stay Afloat.
- Lawrence C. Strauss
-
Moderna Inc. stock falls Wednesday, underperforms market
- MarketWatch Automation
-
Moderna Inc. stock underperforms Tuesday when compared to competitors despite daily gains
- MarketWatch Automation
-
Moderna Inc. stock falls Monday, underperforms market
- MarketWatch Automation
-
Moderna Inc. stock falls Friday, underperforms market
- MarketWatch Automation
-
Moderna Inc. stock underperforms Thursday when compared to competitors
- MarketWatch Automation
-
Moderna Inc. stock falls Wednesday, still outperforms market
- MarketWatch Automation
- Loading more headlines...
Analyst Ratings
-
What Analysts Recommend for Merck in March 2018
- MarketRealist.com
-
5 Biggest Price Target Changes For Friday
- Benzinga.com
Other News on ABBV
-
Top 5 4th Quarter Trades of PARAGON FINANCIAL PARTNERS, INC.
- GuruFocus.com
-
Top 5 4th Quarter Trades of Guinness Asset Management LTD
- GuruFocus.com
-
Drug Prices Rise 5.6% as U.S. Ramps Up Pressure to Lower Costs
- Jared S. Hopkins
-
5 Dividend King Stocks Gurus Are Feasting On
- GuruFocus.com
-
Humira Faces Competition From First U.S. Copycat
- Jared S. Hopkins
-
WD RUTHERFORD LLC's Top 5 Buys of the 4th Quarter
- GuruFocus.com
-
Americana Partners, LLC Buys 2, Sells 3 in 4th Quarter
- GuruFocus.com
-
BTC Capital Management, Inc. Buys 2, Sells 3 in 4th Quarter
- GuruFocus.com
-
Top 5 4th Quarter Trades of WRIGHT INVESTORS SERVICE INC
- GuruFocus.com
-
Sky Investment Group LLC Buys 4, Sells 1 in 4th Quarter
- GuruFocus.com
-
WEDGEWOOD INVESTORS INC /PA/ Goes on Buying Spree in 4th Quarter
- GuruFocus.com
-
The West’s Drug-Price Self-Sabotage
- The Editorial Board
-
PSI Advisors, LLC Buys 1, Sells 4 in 4th Quarter
- GuruFocus.com
-
T Rowe Price Equity Income Fund's Top 4th-Quarter Trades
- GuruFocus.com
-
Fruth Investment Management Buys 1, Sells 4 in 4th Quarter
- GuruFocus.com
-
A New U.S. Law Aims to Reduce Drug Prices. But First, It Might Raise Them
- Jared S. Hopkins
- Loading more headlines...
Press Releases on ABBV
-
Abbvie Inc ABBV Investment Analysis and Advice
- Stock Traders Daily
-
SkinMedica® Launches Even & Correct
- PR Newswire - PRF
-
Abbvie Inc ABBV Pivots Trading Plans and Risk Controls
- Stock Traders Daily
-
Abbvie Inc ABBV Trading Advice
- Stock Traders Daily
-
AbbVie stock up in wake of partnership with Immunome
- PressReach.com
-
AbbVie to Host Fourth-Quarter 2022 Earnings Conference Call
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com